Study period 1 | Study period 2 | |||
---|---|---|---|---|
AST(IU/L) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 36.7 ± 4.7 | 37.0 ± 2.4 | 51.6 ± 5.6 | 41.4 ± 3.4 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 32.5 ± 2.6 | 40.3 ± 4.3 | 39.0 ± 2.2 | 47.5 ± 4.1 |
ALT(IU/L) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 43.3 ± 5.7 | 39.0 ± 3.7 | 55.5 ± 8.1 | 41.2 ± 8.9 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 37.0 ± 4.7 | 42.6 ± 3.8 | 44.5 ± 5.3 | 43.0 ± 5.5 |
ALP(IU/L) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 214 ± 19 | 231 ± 13a | 232 ± 13 | 233 ± 12 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 258 ± 14 | 329 ± 24b | 330 ± 24 | 281 ± 20c |
Study period 1 | Study period 2 | |||
Creatinine (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 0.85 ± 0.04 | 0.93 ± 0.06 | 1.00 ± 0.05 | 0.90 ± 0.05a |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 0.75 ± 0.03 | 0.92 ± 0.03b | 0.91 ± 0.03 | 0.91 ± 0.03 |
Urea (mmol/L) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 4.2 ± 0.34 | 4.1 ± 0.55 | 5.5 ± 0.64 | 3.4 ± 0.28a |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 4.5 ± 0.33 | 4.1 ± 0.24 | 4.2 ± 0.30 | 3.6 ± 0.18 |
CRP (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 3.3 ± 0.74 | 3.4 ± 0.79 | 3.8 ± 1.05 | 3.0 ± 0.58 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 4.3 ± 1.03 | 5.1 ± 0.88 | 5.1 ± 0.88 | 6.0 ± 1.11 |